CREB1 and major depressive disorder: Cyclic adenosine monophosphate-responsive element-binding protein 1 (CREB1), as a representative indicator of the hippocampus of depressed rats, was reported to implicate depression via down-regulation, and thus was considered as the potential target of XYD treatment [51].